Aptamers are composed of short RNA or single‐stranded DNA sequences that, when folded
into their unique 3D conformation, can bind to their targets with high specificity and affinity …

Aptamers are versatile nucleic acid-based macromolecules characterized by their high
affinity and specificity to a specific target. Taking advantage of such binding properties …

Aptamers are single-stranded DNA or RNA with 20-100 nucleotides in length that can
specifically bind to target molecules via formed three-dimensional structures. These …

Nucleic acid ligands, also known as aptamers, are a class of macromolecules that are being
used in several novel nanobiomedical applications. Aptamers are characterized by high …

Aptamers are chemical antibodies possessing the capability of overcoming the limitations
posed by conventional antibodies, particularly for diagnostic, therapeutic, and theranostic …

A wide variety of nanomaterials have emerged in recent years with advantageous properties
for a plethora of therapeutic and diagnostic applications. Such applications include drug …

The active targeting of drugs in a cell-, tissue-or disease-specific manner represents a
potentially powerful technology with widespread applications in medicine, including the …

Aptamers are single-stranded oligonucleotides that specifically bind and interact with their
corresponding targets, including proteins and cells, through unique three-dimensional …

Aptamers are emerging as promising therapeutic agents and recognition elements. In
particular, cell‐SELEX (systematic evolution of ligands by exponential enrichment) allows in …

Aptamer nanomedicine, including therapeutic aptamers and aptamer nanocomplexes, is
beginning to fulfill its potential in both clinical trials and preclinical studies. Especially in …